[Gastrointestinal blood loss after diflunisal]. 1981

P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo

UI MeSH Term Description Entries
D008297 Male Males
D009780 Occult Blood Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood. Fecal Occult Blood Test,Blood, Occult
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D004061 Diflunisal A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN. Apo-Diflunisal,Dolobid,Dolobis,Dolocid,MK-647,Novo-Diflunisal,Nu-Diflunisal,Apo Diflunisal,ApoDiflunisal,MK 647,MK647,Novo Diflunisal,NovoDiflunisal,Nu Diflunisal,NuDiflunisal
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic

Related Publications

P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
June 1979, Lancet (London, England),
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
March 1983, Pharmacotherapy,
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
January 1983, Pharmacotherapy,
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
December 1980, Lakartidningen,
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
December 1982, Clinical rheumatology,
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
March 1983, Pharmacotherapy,
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
September 1981, Clinical pharmacology and therapeutics,
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
January 1983, Pharmacotherapy,
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
June 1979, Lancet (London, England),
P J De Schepper, and T B Tjandramaga, and R Verbesselt, and A Getson, and R Kramp, and M De Roo
August 1977, JAMA,
Copied contents to your clipboard!